Balance Sheet for DARA BioSciences Inc. (DARA)

$ N/A N/A (N/A) Volume: 0 N/A
Statement: View:
Assets [+] in Thousands of Dollars
12/2014 12/2013 12/2012 12/2011 12/2010
Cash and Equivalents 12,027 3,426 6,496 1,179 5,478
Restrictable Cash - - - - -
Marketable Securities - - 96 - -
Accounts Receivable 1,355 174 173 - -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 1,355 174 173 - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other 265 104 125 - -
Inventories, Adjustments & Allowances - - - - -
Inventories 265 104 125 - -
Prepaid Expenses 127 185 153 284 352
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 13,774 3,889 7,045 1,463 5,830
Land and Improvements - - - - -
Buildings and Improvement 12 12 12 12 12
Machinery, Furniture and Equipment 204 204 192 176 179
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 215 216 203 188 191
Gross Fixed Assets 215 216 203 188 191
Accumulated Depreciation (180) (175) (153) (145) (127)
Net Fixed Assets 36 41 50 42 63
Intangibles 3,109 3,225 3,709 100 -
Cost in Excess 821 821 821 - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 13 13 13 39 51
Total Non-Current Assets 3,979 4,099 4,647 389 613
Total Assets 17,752 7,988 11,692 1,852 6,443
Liabilities [+] in Thousands of Dollars
12/2014 12/2013 12/2012 12/2011 12/2010
Accounts Payable 483 620 1,383 641 350
Short Term Debt 7 4 7 15 13
Notes Payable - - - - -
Accrued Expenses 1,823 909 499 212 552
Accrued Liabilities 1,823 909 499 212 552
Deferred Revenues 200 142 150 - -
Current Deferred Income Taxes - 29 (1,300) - -
Other Current Liabilities 1,232 - - - -
Total Current Liabilities 3,745 1,675 2,039 868 915
Long Term Debt 22 16 20 16 31
Deferred Income Tax 69 73 41 9 12
Other Non-Current Liabilities 69 735 640 9 300
Minority Interest - (1,047) (645) (215) 91
Capital Lease Obligations 22 16 20 16 31
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 91 (296) 16 (190) 422
Total Liabilities 3,836 1,379 2,055 678 1,337
Preferred Shareholder's Equity 0 0 0 0 0
Common Shareholder's Equity 13,916 6,609 9,638 1,174 5,106
Common Par 198 310 189 56 41
Additional Paid in Capital 79,712 63,292 56,430 40,835 38,610
Cumulative Translation Adjustments - - - - -
Retained Earnings (65,994) (56,993) (47,028) (39,717) (33,546)
Treasury Stock - - - - -
Other Equity Adjustments - - 45 - -
Total Capitalization 13,916 6,609 9,638 1,174 5,106
Total Equity 13,916 6,609 9,638 1,174 5,106
Total Liabilities & Shareholder's Equity 17,752 7,988 11,692 1,852 6,443
Cash Flow (9,944) (11,064) (8,418) (6,477) (5,992)
Working Capital 10,028 2,214 5,006 595 4,916
Free Cash Flow (7,989) (9,142) (7,289) (4,861) (5,116)
Invested Capital 13,916 6,609 9,638 1,174 5,106
Shares Outstanding - Common Class Only 19,756 6,195 3,789 1,120 825
Preferred Shares Outstanding 1 1 2 1 4
Total Ordinary Shares 19,756 30,974 18,947 5,601 4,126
Total Common Shares Outstanding 19,756 6,195 3,789 1,120 825
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 14,305 5,132 2,422 1,030 626
Diluted Weighted Shares Outstanding 14,305 5,132 2,422 1,030 626